Literature DB >> 3659919

Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon.

S H Chen1, G Habib, C Y Yang, Z W Gu, B R Lee, S A Weng, S R Silberman, S J Cai, J P Deslypere, M Rosseneu.   

Abstract

The primary structure of human apolipoprotein (apo) B-48 has been deduced and shown by a combination of DNA excess hybridization, sequencing of tryptic peptides, cloned complementary DNAs, and intestinal messenger RNAs (mRNAs) to be the product of an intestinal mRNA with an in-frame UAA stop codon resulting from a C to U change in the codon CAA encoding Gln2153 in apoB-100 mRNA. The carboxyl-terminal Ile2152 of apoB-48 purified from chylous ascites fluid has apparently been cleaved from the initial translation product, leaving Met2151 as the new carboxyl-terminus. These data indicate that approximately 85% of the intestinal mRNAs terminate within approximately 0.1 to 1.0 kilobase downstream from the stop codon. The other approximately 15% have lengths similar to hepatic apoB-100 mRNA even though they have the same in-frame stop codon. The organ-specific introduction of a stop codon to a mRNA appears unprecedented and might have implications for cryptic polyadenylation signal recognition and RNA processing.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3659919     DOI: 10.1126/science.3659919

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  189 in total

1.  Identification of editing positions in the ndhB transcript from maize chloroplasts reveals sequence similarities between editing sites of chloroplasts and plant mitochondria.

Authors:  R M Maier; K Neckermann; B Hoch; N B Akhmedov; H Kössel
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

2.  An in vitro system for the editing of ATP synthase subunit 9 mRNA using wheat mitochondrial extracts.

Authors:  A Araya; C Domec; D Begu; S Litvak
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

3.  Molecular characterization of two types of 22 kilodalton alpha-zein genes in a gene cluster in maize.

Authors:  C N Liu; I Rubenstein
Journal:  Mol Gen Genet       Date:  1992-08

4.  Selenocysteine inserting tRNAs are likely generated by tRNA editing.

Authors:  A M Diamond; Y Montero-Puerner; B J Lee; D Hatfield
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

Review 5.  When you can't trust the DNA: RNA editing changes transcript sequences.

Authors:  Volker Knoop
Journal:  Cell Mol Life Sci       Date:  2010-10-12       Impact factor: 9.261

6.  Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism.

Authors:  J R Morrison; C Pászty; M E Stevens; S D Hughes; T Forte; J Scott; E M Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

7.  Genetic Architectures of Quantitative Variation in RNA Editing Pathways.

Authors:  Tongjun Gu; Daniel M Gatti; Anuj Srivastava; Elizabeth M Snyder; Narayanan Raghupathy; Petr Simecek; Karen L Svenson; Ivan Dotu; Jeffrey H Chuang; Mark P Keller; Alan D Attie; Robert E Braun; Gary A Churchill
Journal:  Genetics       Date:  2015-11-27       Impact factor: 4.562

Review 8.  Hepatic ABCA1 and VLDL triglyceride production.

Authors:  Mingxia Liu; Soonkyu Chung; Gregory S Shelness; John S Parks
Journal:  Biochim Biophys Acta       Date:  2011-10-06

Review 9.  Recent advances in lipoprotein and atherosclerosis research at Baylor College of Medicine. Apolipoprotein B, lipoprotein[a], and transplantation arteriopathy.

Authors:  C M Ballantyne; L Chan; J Guevara; J D Morrisett; M P Mims; A M Gotto
Journal:  Tex Heart Inst J       Date:  1994

10.  apo B gene knockout in mice results in embryonic lethality in homozygotes and neural tube defects, male infertility, and reduced HDL cholesterol ester and apo A-I transport rates in heterozygotes.

Authors:  L S Huang; E Voyiaziakis; D F Markenson; K A Sokol; T Hayek; J L Breslow
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.